Ajinomoto and Accenture to Establish Joint Venture to Help Drive Ajinomoto’s Operational Transformation
TOKYO; Nov. 7, 2019 – Ajinomoto Co., Inc. and Accenture (NYSE: ACN) have agreed to establish a joint venture in Japan to help the food and biotech company accelerate its operational transformation.
November 07, 2019
Accenture to Help Santen Pharmaceutical Build a Global Intelligent Enterprise Platform on SAP® S/4HANA® to Drive Its Digital Transformation
TOKYO; Oct. 30, 2019 – Accenture (NYSE: ACN) has been selected to help Santen Pharmaceutical Co., Ltd. (Santen), an ophthalmic pharmaceutical company headquartered in Japan, build a global intelligent enterprise platform that will drive the company’s digital transformation.
October 30, 2019
Accenture Announces Collaboration with Bayer to Streamline Drug Development Processes through INTIENT Clinical Platform
NEW YORK; Sept. 16, 2019 – Accenture (NYSE: ACN) has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve patient outcomes.
September 16, 2019
Better Collaboration Between Pharma and Patient Organizations Would Improve Patient Care, Accenture Study Finds
FRANKFURT and NEW YORK; Aug. 6, 2019 ‒ To deliver better patient experiences, pharmaceutical companies should collaborate with nonprofit organizations that provide support services and advocate for patients, according to a new study from Accenture (NYSE: ACN).
August 07, 2019
Accenture Introduces INTIENT™, an Innovative Platform to Advance the Discovery, Development and Delivery of Patient Treatments
NEW YORK; May 16, 2019 – Accenture (NYSE: ACN) today introduced INTIENT™, a technology platform that vastly improves the continuity and flow of data across life sciences enterprises, supporting the delivery of ground-breaking treatments for patients.
May 16, 2019
Accenture Completes Acquisition of ESP
NEW YORK and DUBLIN, Ireland; May 1, 2019 – Accenture (NYSE: ACN) has completed the acquisition of Enterprise System Partners (ESP), a consulting and manufacturing services provider for the life sciences industry that is headquartered in Cork, Ireland.
May 01, 2019
“New Science” is Leading Growth While Changing the Market Dynamics of the Biopharma Industry, According to New Research from Accenture
NEW YORK; April 4, 2019 – The adoption of a unique combination of the best in science and health technology such as genomics, biomarkers and companion technologies are expected to be the biopharmaceutical industry’s new growth machine, according to new research from Accenture (NYSE: ACN).
April 04, 2019
Accenture to Acquire ESP to Help Life Sciences Clients Digitize and Transform Manufacturing Operations
NEW YORK and DUBLIN, Ireland; Mar. 5, 2019 – Accenture (NYSE: ACN) has agreed to acquire Enterprise System Partners (ESP), a consulting and manufacturing services provider for the life sciences industry that is headquartered in Cork, Ireland, serving clients around the globe. Upon close, ESP will join Accenture Industry X.0, which helps clients master the digital reinvention of industry, strengthening Accenture’s capabilities to transform manufacturing for pharmaceutical, biotech and medical device clients globally.
March 05, 2019
Ayasdi Named Accenture HealthTech Innovation Challenge Innovation Champion
SAN FRANCISCO; Jan. 8, 2019 – Ayasdi has been named the Accenture HealthTech Innovation Challenge Innovation Champion, competing with more than 1,100 companies for the title. The competition pairs leading-edge startups with prominent health and life sciences organizations to develop innovative technology solutions that improve the way people access and manage healthcare.
January 08, 2019
Four Finalists in US and Canada Selected for Accenture HealthTech Innovation Challenge
NEW YORK; Dec. 21, 2018 – Using conversational artificial intelligence to improve care management and leveraging patient experiences to incentivize patients in their own health journey are among the innovative solutions being developed by the four North America-based finalists selected for the Accenture HealthTech Innovation Challenge.
December 21, 2018